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Abstract
In recent years, next-generation sequencing (NGS) platforms that facilitate 
generation of a vast amount of genomic variation data have become widely used 
for diagnostic purposes in medicine. However, identifying the potential effects of 
the variations and their association with a particular disease phenotype is the main 
challenge in this field. Several strategies are used to discover the causative mutations 
among hundreds of variants of uncertain significance. Incorporating information 
from healthy population databases, other organisms’ databases, and computational 
prediction tools are evolution-based strategies that give valuable insight to interpret 
the variant pathogenicity. In this chapter, we first provide an overview of NGS 
analysis workflow. Then, we review how evolutionary principles can be integrated 
into the prioritization schemes of analyzed variants. Finally, we present an example 
of a real-life case where the use of evolutionary genetics information facilitated the 
discovery of disease-causing variants in medical genomics.
Keywords: genomics, evolution, variant discovery
1. Introduction
NGS technologies can be integrated into medical diagnostics in several ways 
which vary in the number and type of sequenced regions. While targeted tests 
include sequencing particular disease-specific genes, sequencing all ~20,000 
protein-coding genes by Whole-exome sequencing (WES) and entire genomes by 
Whole-genome Sequencing (WGS) are non-targeted approaches. These sequencing 
approaches are precise ways to detect genetic variation of a patient and in relation to 
a healthy population or healthy reference genome. However, sequencing-based diag-
nostic methods generate large amounts of genomic data. Approximately, 60,000–
100,000 single nucleotide variations (SNV) and small insertions and deletions 
(indel) in each patient’s personal genome can be detected on WES [1]. Translating 
these high numbers of genomic variants into useful clinical information is a crucial 
task. Although several methods have been introduced to help reduce the vast number 
of possible genes to clinically causative ones, this process still remains challenging.
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Disease-related genes show non-random distribution characteristics in the 
genome with the majority of them being already present in the eukaryotic ancestor 
[2]. Mendelian disease genes that underlie single-gene disorders tend to have a more 
ancient evolutionary origin [3]. Considering disease-related genes have evolved 
under the effect of natural selection like other genes, evolutionary approaches can 
provide powerful insight not only to understand human genetic diseases but also to 
detect genomic variants that cause them.
Here, we briefly describe the analysis workflow from raw data to genomic vari-
ants as the first step of the translation to the clinical outcome. We primarily focus on 
WES analysis because most variations that are responsible for Mendelian disorders 
disrupt protein-coding regions [4]. Then we give an insight into how evolutionary 
principles are integrated into the prioritization of detected variants. The framework 
of the chapter can be found in Figure 1.
2. From raw data to genomic variations
The common file format for the storage of data produced by sequencers is 
FASTQ [5]. FASTQ format stores both nucleotide sequence and its corresponding 
Phred quality scores [6, 7]. The Phred score related to the base-calling error prob-
abilities indicates the quality of each nucleotide within a read. In a FASTQ file, each 
read is shown by four lines: The first line begins with a “@” and continues with a 
sequence identifier and an optional description. The second line consists of the 
raw sequence letters: A, T, G, C, and N (unknown). The third line starts with a “+” 
Figure 1. 
A general workflow for WES data analysis. Six main steps, quality assessment & preprocessing, alignment, 
post-alignment processing, variant calling, variant annotation, and variant prioritization integrated with 
evolutionary approaches, are shown.
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character and can be followed by the same sequence identifier again. The “+” sign 
specifies the end of the sequence. The fourth line includes the quality scores for the 
sequence in the second line.
Here, we give an overview of the data analysis workflow from a FASTQ file to 
obtain annotated genomic variants.
2.1 Quality assessment and preprocessing
Although NGS platforms are capable of generating massively parallel sequences 
even in a single run, the quality of sequencing reads may not be perfect due to some 
reasons such as the failure in experimental processing and technical machine errors. 
The quality of raw FASTQ data should be assessed in the first step of the workflow 
since these errors affect downstream analysis.
A number of tools have been developed to evaluate raw FASTQ data. These tools 
generally take FASTQ files as input and generate summary statistics and graphs for 
a quick overview of the raw read quality. In addition to the most commonly used 
one FASTQC [8], developed by Simon Andrews at Babraham Institute, other tools 
are also available such as FQStat [9], Quack [10], SeqAssist [11], QC-Chain [12]. 
Based on the result of the quality check step, if there is a need, preprocessing is 
necessary before alignment.
The standard preprocessing step consists of trimming of low-quality bases and 
adapter sequence removal at the end of the reads. Adapter sequences can be ligated 
to 3′ and 5′ ends of reads depending on the used library preparation protocol during 
the sequencing. These adapter fragments should be removed correctly because of 
leading to either missed alignments or wrong genotyping in further downstream 
analyses. Many tools with different principles of implementation have been 
developed to perform preprocessing. Ktrim [13], PE-Trimmer [14], SeqPurge [15], 
AdapterRemoval [16], PEAT [17], Skewer [18], Trimmomatic [19], QcReads [20], 
AlienTrimmer [21], and Btrim [22] are tools can be used for adapter and quality 
trimming depending on the study design. In addition to these, some tools such as 
FastqCleaner [23], FastProNGS [24], EasyQC [25], fastp [26], TrimGalore, FASTX-
Toolkit, afterQC, ClinQC, NGS QC Toolkit, PRINSEQ , fastQ _brew carry out both 
quality check and preprocessing functions.
2.2 Alignment of reads
After quality check and preprocessing of raw data, processed reads must be 
aligned to the reference genome. Both GRCh37 (hg19) and GRCh38 (hg38) are 
widely used as a reference for the human genome. Optimal alignment to reference 
sequences is not easy computational task and requires a fast and tolerant algo-
rithm to obtain an imperfect alignment due to genomic variations. Several tools 
have been developed to align short reads. They mainly use the Burrows-Wheeler 
Transformation (BWT) algorithm, the Smith-Waterman (SW) dynamic program-
ming algorithm or a combination of both of them. Bowtie2 [27] and BWA [28], 
which implement the BWT algorithm, are widely used for short reads alignment. 
Novoalign [29], MOSAIK [30], and SHRiMP2 [31] implement SW algorithm. For a 
comprehensive review of these methods and their differences, benchmark studies 
can be found in the literature [32, 33].
The output of the alignment step is the Sequence Alignment Map (SAM) 
file which contains mapped reads. BAM stands for Binary Alignment Map and 
is the binary version of a SAM file. Both BAM files and SAM files have the same 
information which include a header and an alignment section. The header section 
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provides some information such as reference sequence, read group, sequencing 
platform details and applied process information to the reads. The alignment sec-
tion includes the genomic position with relevant descriptive information of each 
sequence.
SAMtools [34] and Integrative Genomics Viewer (IGV) [35] are also com-
monly used programs to view BAM/SAM files for further confirmation analysis of 
detected variants.
2.3 Post-alignment processing
Processing of aligned reads is recommended to improve the quality of down-
stream variant calling analysis. The processing step generally consists of marking 
read duplicates and base quality score recalibration (BQSR) to minimize technical 
biases.
During the sequencing, a library of DNA fragments from a particular genomic 
region is prepared using PCR amplification to provide adequate DNA fragments for 
the sequencing process. Therefore, some amplified fragments could share the same 
sequence and the same corresponding alignment position leading to bias in variant 
detection. These duplicates should be removed to eliminate PCR-introduced bias. 
MarkDuplicates available in the Picard [36] and SAMtools [34] are widely-used 
tools to detect read duplicates based on their identical 5′ region and position on 
the genome.
In addition to marking duplicates, base quality is also an important factor for 
variant detection. As mentioned in the section “Quality check and preprocessing”, 
each sequence read has a Phred quality score generated by the sequencing machine. 
However, the machine could generate systematically biased scores. On the contrary, 
BQSR patterns errors empirically to recalibrate the base quality scores using a 
machine learning approach. Thus, technical bias is significantly minimized. The key 
point in this process is to exclude known variants before BQSR since they are true 
genomic variations. So, they should not be considered as sequencing errors. The 
most widely used tool for recalibration of base qualities is BaseRecalibrator available 
in Genome Analysis Toolkit (GATK) [37].
2.4 Variant calling
After the post-alignment processing step, variant analysis can be started on an 
analysis-ready BAM file. In the variant calling step, the differences between the ref-
erence genome and genome of interest are calculated. Variants can be categorized as 
germline and somatic variants while dealing with variant calling. Germline variants 
are inherited variations present in the germ cells. Somatic variants are present only 
in somatic cells and can be specific to a tissue. In this chapter, we focus on the iden-
tification of germline SNV and indels. Several tools based on different algorithms 
have been developed to call germline short variants. Tools such as HaplotypeCaller 
available in GATK [38], SAMtools [34], FreeBayes [39], and Platypus [40] are based 
on Bayesian approaches. VarScan [41] relies on a heuristic approach to identify vari-
ants, while SNVer [42] uses a frequentist approach. The performance of different 
tools has been evaluated by recent studies [43–45], yet, these tools mostly gener-
ate an analysis-ready VCF (Variant Call Format) file. A VCF file is a text file that 
contains header lines and data lines. The header lines begin with “##” symbol. The 
first header line is always the VCF format version and continues with lines defining 
the name, length, value type, and description of each item in relevant fields of each 
data line.
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2.5 Variant annotation and prioritization
After variants are detected, biologically important features such as gene sym-
bols, genomic position, amino acid change, and consequences of variants add to a 
VCF file in the annotation step. In addition to the basic annotation, several tools can 
be used to integrate the annotations from countless sources including information 
of known variants with minor allele frequency (MAF) found in public databases 
and pathogenicity prediction of variants. There are numerous variant annotation 
tools that implement different methods and most widely used ones are AnnoVar 
[46], VEP [47], SnpEff [48], GEMINI [49], VarAFT [50], AnnTools [51], SVA [52], 
NGS-SNP [53]. These annotation tools enable to filtering and prioritizing potential 
disease-causing mutations. The prioritization of clinically causative mutation 
among a vast amount of annotated variations is the most challenging part of the 
analysis and is not a fully automatized. In the next section, we are going to discuss 
how evolutionary approaches can be used to prioritize genomic variants.
3. Utilizing evolutionary information in variant prioritization
We have described the process of obtaining annotated variations from raw FASTQ 
data. Experimentally evaluation of each variant at a genomic scale would be an imprac-
tical process, but evolutionary principles can provide us a valuable set of an experiment 
from nature. Integrating evolutionary approaches into the prioritization step have the 
potential to distinguish the variant responsible for a particular disease among all anno-
tated variants. Indeed, the association between disease and evolution has been attrib-
uted to natural selection [54, 55]. During evolution, variations at highly conserved 
genomic regions are exposed to natural selection because of their negative impact on 
fitness that make these conserved genes intolerant to variations [56]. On the contrary, 
at the faster-evolving regions of the genome, many variations have been tolerated over 
evolutionary time and accumulate in the population with high MAF. However, there is 
a predisposition for Mendelian disease genes to be more intolerant than the other genes 
[57]. These genes are also more conserved across species allowing us to compare the 
phenotypes of different mutant genes on a multispecies level [58].
In this part, we discuss the role of evolutionary approaches in variant prioritiza-
tion. The first prioritization method aims to filter variants using information from 
allele frequencies in population databases. Then we introduce several pathogenicity 
prediction tools to interpret the rest of the variants, especially the ones with uncer-
tain significance. Following that, we describe the usage of gene intolerance infor-
mation while making inference the variant pathogenicity. Finally, we list commonly 
used model organism databases that can be used for the comparison of mutant gene 
phenotypes in several species.
3.1 Population databases
During human evolution, present and novel variations have been evaluated 
in terms of their biological impact. Population databases record the outcomes 
of genetic variations providing an extensive catalog that include thousands of 
individuals’ genomic variations to researchers. At the end of the 1990s, the estab-
lishment of dbSNP has led to record genotype-phenotype associations via variant 
databases [59]. Latterly, large-scale projects such as gnomAD and 1000 Genome 
Project Databases that actively collect genomic data from various populations have 
become available MAF at population level found in these databases is one of the 
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primary guides to interpret that variant pathogenicity. Because causative variants 
related to most Mendelian disorders have deleterious effects on reproductive fitness. 
Generally, causative alleles are less likely to reside in these databases or are present 
with low frequencies. In any global population database, except for the well-known 
founder alleles, >5% MAF can be considered as benign [60]. Therefore, a subset 
of the total number of variants inside these databases can be used for variant 
filtration. This is often achieved according to three different approaches. The first 
approach, called discrete filtering, assumes that a disease-causing variant should 
not found in these databases [61, 62]. This approach can be useful for very rare 
Mendelian disorders, but it can be problematic in some cases. Excluding observed 
alleles, independent from their MAF, can lead to the elimination of truly pathogenic 
alleles found in the general population at low frequencies because of the increas-
ing number of genomes in databases. Especially, elucidating autosomal recessive 
disorders are affected by this risk. The second approach, called 1%-approach, is 
based on allele frequency thresholds that change according to the inheritance model 
of variants. While the analysis of autosomal recessive variants MAF threshold can 
be set at 1%, MAF cutoff of 0.1% can be useful for autosomal dominant variants 
[62]. Alternatively, the third approach, called the quantile-based approach, employs 
frequency thresholds as in the previous method. However, the thresholds in the 
quantile-based method are variable and depend on disease prevalence, mode of 
inheritance, database size, and database characteristics [63].
Depending on the case, different approaches can be employed using population 
databases with different scopes and data collection. Here, we summarize the widely 
used population databases. 1000 Genome Project (1KGP) Database.
3.1.1 1000 Genome Project (1KGP) database
1KGP database provides a comprehensive set of human genetic variations from a 
diverse set of individuals of multiple populations. The database includes the recon-
structed genomes of 2504 individuals from 26 populations obtained by combining 
low-coverage whole-genome sequencing, deep exome sequencing, and dense micro-
array genotyping. The database contains over 88 million variants, which consist of 
around 84.7 million SNPs, 3.6 million indels, and 60,000 structural variants [64, 65].
3.1.2 The Genome Aggregation Database (gnomAD)
gnomAD is an extensive collection of exome and genome sequencing data from 
several large-scale sequencing projects. The first release of gnomAD is also known 
as the Exome Aggregation Consortium (ExAC) dataset. gnomAD short variant 
v2 release contains 125,748 exomes, and 15,708 whole genomes mapped to the 
GRCh37/hg19 reference sequence. In contrast, the short variant v3 release contains 
71,702 whole genomes, including most of the whole genomes from v2 release 
mapped to the GRCh38 reference sequence. Therefore, gnomAD v2 provides higher 
power for the analysis of the coding regions, while v3 offers a valuable resource for 
the analysis of non-coding regions. For the analysis of structural variants, gnomAD 
SV v2.1 data set grants access to a total of 10,847 genomes aligned against the 
GRCh37 reference sequence [66].
3.1.3  Database of short genetic variations (dbSNP) and the database of genomic 
structural variations (dbVar)
The National Center for Biotechnology Information (NCBI) maintains dbSNP 
and dbVar databases which together contain almost 2 billion submitted human 
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variants. Although dbVar does not have a reference structural variant database 
since the current technology cannot detect the precise breakpoints in the genome, 
dbSNP presents the reference variants as rs identifiers. Other contents of the dataset 
include population frequency, geographic origin of the population, population-spe-
cific genotype and allele frequencies as well as population-specific heterozygosity 
estimates. Besides serving as a human population database, dbSNP and dbVar also 
contain a variety of organisms´ genomic variations that can be a valuable resource 
for evolutionary studies [67, 68].
3.1.4 ClinVar
ClinVar is a public database that archives genetic variances of any type and the 
interpretations of their clinical significance for reported conditions. Unlike dbSNP 
and dbVar that are also maintained by NCBI, ClinVar only focuses on the medi-
cally relevant variations. Although ClinVar reviews the submissions of variants for 
validation, the clinical significance of the variants is reported directly from submit-
ters. ClinVar displays any conflict between the interpretations for the same variant 
from different submitters or the consensus. In the strict comparison approaches, the 
algorithm evaluates submissions for a variant to be pathogenic and likely pathogenic 
as conflicting. In the more relaxed approach, the variants can be categorized as 
pathogenic/likely pathogenic, benign/likely benign, or uncertain significance [69].
3.1.5  Database of chromosomal imbalance and phenotype in humans using 
Ensembl resources (DECIPHER)
DECIPHER provides a catalog of common copy-number changes in healthy 
populations as well as chromosome rearrangements of patients and their phenotype 
record submitted by clinical researchers upon informed consent [70]. Therefore, 
DECIPHER can serve as a valuable platform during variant prioritization. Users can 
check both the healthy population database and the previously submitted clinical 
records within DECIPHER to understand the effect of the variant of interests better 
and to identify novel and potentially pathogenic variants.
3.2 Pathogenicity prediction tools
Even population MAF-based filtering, individuals generally have many variants 
that are not present in databases. Most of these variants do not classify definitively 
as benign or pathogenic according to criteria proposed by some clinical guidelines 
such as the American College of Medical Genetics and Genomics (ACMG) [60]. 
These types of alterations termed variants of uncertain significance (VUS). Further 
filtering approaches must use to reduce the number of VUS. For this purpose, 
numerous pathogenicity prediction tools based on different principles have been 
developed to evaluate the variant effect. ACMG and the European Society of 
Human Genetics (ESHG) [71] guidelines also recommend these in-silico methods 
to interpret variant pathogenicity.
The first methods were proposed to predict computationally whether an amino 
acid substitution will disturb the protein function. These methods, now part of the 
PolyPhen algorithm [72], use physical properties of the mutational change along 
with a multispecies alignment as a basis to evaluate mutations. Many methods have 
been derived from this idea and are based on different principles. Evolutionary 
conservation is among the most useful features for such predictions. Some 
methods such as SIFT [73], PROVEAN [74] and PANTHER [75] rely on sequence 
conservation. For example, SIFT, as the most widely used algorithm, compares the 
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alignments of related sequences by performing a PSI-BLAST search to check if the 
variant is tolerated in an evolutionary aspect. In addition to sequence conserva-
tion, another group of methods which take into account several features such as 
amino acid physicochemical properties, the context of variation position, protein 
structural features through machine learning algorithms are also available. CADD 
[76], MutationTaster2 [77], PolyPhen-2 [72], DANN [78] and VEST3 [79] are well-
known examples of such tools.
The predicted impact of a variation obtained from different tools may not be the 
same. This problem led to researchers making efforts to develop meta predictors 
that combine the results from existing tools by using several approaches such as 
logistic regression, decision trees, random forests, and support vector machines to 
make their own decisions. MetaSVM and MetaLR [80], M-CAP [81] and REVEL 
[82] are well-known examples of meta-predictors.
Below, several useful tools are explained without a performance comparison. 
However, various benchmark studies that have extensively examined the accuracy 
of these tools can be found in the literature [83–85].
3.2.1 MutationTaster2
MutationTaster2, using a naive Bayes classifier, predicts the functional con-
sequences of variants that are both in exonic and intronic regions by incorporat-
ing a scoring system for the evolutionary conservation around DNA variants. 
MutationTaster uses information from several variant databases, including 1KGP and 
ClinVar. The tool automatically predicts a variant as neutral if it is found more than 
four times in the homozygous state in these databases and as disease-causing if it is 
reported as pathogenic in ClinVar by listing the associated disease phenotypes [77].
3.2.2 Combined annotation-dependent depletion (CADD)
CADD combines 63 genomic features derived from evolutionary constraint, 
surrounding sequence context, and functional predictions to evaluate SNVs and 
short indels. The tool integrates all of these features into a single CADD score using 
a machine learning approach trained on a binary distinction between simulated 
variants and variants that have become fixed in human populations since the split 
between humans and chimpanzees. C scores correlate with pathogenicity of a vari-
ant and disease severity [76].
3.2.3 The Mendelian clinically applicable pathogenicity (M-CAP)
M-CAP uses a supervised learning classifier to interpret genomic variants 
and focus especially on coding mutations for Mendelian diseases. As a meta-
predictor, it uses nine existing tools SIFT, PolyPhen-2, CADD, MutationTaster, 
MutationAssessor [86], FATHMM [87], LRT [88], MetaLR and MetaSVM. It also 
combines information of base-pair, amino acid, genomic region, and gene con-
servation from RVIS [89], PhyloP [90], PhastCons [91], SIPHY [92], GERP [93], 
PAM250 and BLOSUM62 [94]. Additionally, M-CAP establishes multiple-sequence 
alignments of 99 primate, mammalian, and vertebrate genomes to the human 
genome as a new feature [81].
3.2.4 PrimateAI
PrimateAI [95] is a deep neural network trained by a comprehensive dataset 
that includes around 380,000 common missense variants from humans and six 
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non-human primate species. PrimateAI categorizes the common missense muta-
tions from other primate species as non-pathogenic for humans. Thus, it enables 
the identification of the pathogenic variants. PrimateAI has previously shown 88% 
accuracy in disease-causing variant identification and allowed the discovery of 14 
novel candidate genes related to intellectual disability. PrimateAI also incorporates 
protein structure information as it learns to predict the secondary structure and 
solvent accessibility from amino acid sequences. PrimateAI provides a score to 
the user in which a threshold of >0.8 is for likely pathogenic classification, <0.6 
is for likely benign, and 0.6–0.8 is as intermediate in genes with dominant modes 
of inheritance, and a threshold of >0.7 is for likely pathogenic and <0.5 for likely 
benign in genes with recessive modes of inheritance.
3.3 Genic intolerance
Genic intolerance is a gene-level assessment that has a potential to prioritize 
genomic variants. It has been developed as a scoring system to calculate tolerance 
of genes to a functional genetic variation on a genome-wide scale and rank them 
using 6503 WES data available in the National Heart, Lung, and Blood Institute-
NHLBI Exome Sequencing Project [89]. This system predicts the expected common 
functional variation in the gene and compares them to apparently neutral variation 
found in the gene. The deviation from this prediction is attributed to the intolerance 
score, namely the Residual Variation Intolerance Score (RVIS). While genes with a 
positive RVIS score have more common functional variation than expected, genes 
with negative RVIS scores have less. A negative RVIS score indicates that the gene 
is intolerant. The scoring system also shows that the genes that cause Mendelian 
diseases are significantly more intolerant to functional variation than genes that do 
not cause any known disease.
3.4 Model organism databases
The evolutionary conservation of many biological processes among species 
allows the usage of several different model organisms to study human diseases. 
Although not all the human genes are conserved in invertebrate models such as 
worms and fruit flies, vertebrate models such as zebrafish and mouse provide 
valuable resources to study such genes. When evaluating the function of a con-
served gene in model organisms, it is critical to keep in mind that orthologous genes 
usually cause different phenotypes in different species, although the gene products 
have a similar molecular function. The model organism databases listed below 
provide the related information on the molecular function of query genes so that 
they serve as a valuable resource during the variant prioritization process.
3.4.1 Mouse genome informatics (MGI)
MGI is the primary database that integrates genetic, genomic, and biological 
data for the laboratory Mouse. Mouse Genome Database (MGD) and Mouse Gene 
Expression Database (GXD) are the two largest contributors to MGI, both serv-
ing as valuable resources for the studies of human disease. MGD provides curated 
phenotypes and functional annotations for mouse genes and alleles, while GXD 
contains mouse gene expression data with an emphasis on endogenous gene expres-
sion during mouse development [96, 97]. The Human-Mouse Disease Connection 
tool within MGI is another important feature that facilitates exploring gene-phe-
notype-disease relationships between human and mouse. By simply searching the 
list of human genes on MGI, the algorithm finds matching mouse genes and their 
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homologs and displays the both human and mouse phenotypes associated with the 
genes of interest. MGI is updated once every week by adding new annotations from 
the literature.
3.4.2 International Mouse Phenotyping Consortium (IMPC)
IMPC aims to establish a comprehensive dataset of mouse genome and phenome 
by knocking out each gene individually and characterizing the physical and chemi-
cal changes, thus providing the foundations for the functional analysis of human 
genetic variation [98]. The project also aims to generate putative human pathogenic 
variants in both coding and non-coding regions of the mouse genome.
IMPC uses an algorithm that has been developed to detect phenotypic similari-
ties between the mouse strains of IMPC and more than 7000 rare diseases. The 
algorithm evaluates a very diverse set of phenotyping parameters that comprise 
neurological, behavioral, metabolic, cardiovascular, pulmonary, reproductive, 
respiratory, sensory, musculoskeletal, and immunological parameters and provides 
a quantitative measure on how well a mouse model recapitulates disease features.
So far, over 3000 genes have already been cataloged and revealed models for 360 
diseases, with 90% of the annotated phenotypes being novel [99]. By 2021, IMPC 
plans to analyze more than 9000 mouse genes to facilitate the prioritization and 
validation of variations obtained from clinical sequencing efforts.
3.4.3 Rat Genome Database (RGD)
RGD provides genetic, genomic, phenotypic, and disease-related data for the 
laboratory rat, Rattus norvegicus. Rats have been one of the most commonly used 
model organisms for human disease research. RGD catalogs the rat data and also 
serves as a comparative data analysis platform between species such as rat, mouse, 
and human by validating the orthologous relationships. The database currently 
contains more than 1300 rat strains with disease/phenotype annotations [100].RGD 
contains several tools that facilitate the analysis of data in disease-related content. 
PhenoMiner is such a tool that standardizes the phenotype data obtained from dif-
ferent rat studies by using a variety of ontologies developed at RGD [101]. Users can 
select one of the Phenominer search categories that include rat strains, experimen-
tal conditions, clinical measurements, and measurement methods to begin their 
search. Then, the algorithm filters the data according to the selected conditions and 
displays the results.
3.4.4 FlyBase
FlyBase is the central resource for integrated Drosophila genetic and genomic 
data, including but not limited to sequence-level gene models, mutant phenotypes, 
mutant lesions and chromosome aberrations, as well as gene expression patterns 
[102]. The fruit fly—Drosophila melanogaster—is a member of the Drosophila family 
widely used as a model for human disease research.
FlyBase allows different approaches for data presentation to facilitate Drosophila 
translational research as the two main methods being the gene-centric and disease-
centric ones. The Gene Report displays information on individual genes. The report 
also lists the mutant alleles of the gene and the expression pattern of the gene 
products. The Human Disease Model Report provides background information on a 
specific disease and presents summaries of the experimental data and results from 
previous fruit fly studies.
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FlyBase also incorporates orthology prediction tools such as OrthoDB and 
DIOPT that have been developed to identify orthologs of fly genes in multiple 
organisms [103, 104]. Integrating the results of these tools to the Gene Reports 
provides users the identification of orthologs in up to 5000 species. The predicted 
orthologs serve as a valuable resource for the human disease gene variants predic-
tion as FlyBase also indicates whether the human ortholog functionally comple-
ments the fly mutant upon transfer into the Drosophila genome.
3.4.5 WormBase
WormBase serves as the main database for genetic, genomic, and biological 
information on C.elegans and related nematodes. C. elegans is a widely used model 
for human disease variant research as over 40% of human genes have a C.elegans 
ortholog. WormBase catalogs the available mutant strains for each gene as well 
as related nematode studies. WS273 release of WormBase contains over 160,000 
gene summaries for 10 nematode species. The gene summaries also include human 
ortholog diseases and phenotypes to aid the detection of human disease-causing 
variants [105].
3.4.6 Zebrafish Information Network (ZFin)
ZFIN is the main database that provides genetic, genomic, and phenotypic 
data from zebrafish studies [106]. Zebrafish—Danio reriro—is a model organ-
ism extensively used in biomedical research, especially for developmental and 
genomic studies. Powerful approaches are available to model human diseases using 
zebrafish. Genetic manipulation of zebrafish orthologs of human disease genes is a 
common strategy to model genetic disorders such as Duchenne muscular dystrophy 
[107] and Rett Syndrome [108]. Another strategy of disease modeling is generating 
transgenic zebrafish lines that express human genes. This approach allows testing 
the function of the potential disease-causative variant in disease pathology. For 
example, a transgenic zebrafish model confirmed the pathogenicity of two novel 
XPNPEP3 gene mutations predicted to be ciliopathy-causing in the clinic [109]. 
Users can easily search ZFIN to reach information on disease models, including the 
transgenic lines and mutant phenotypes related to their query.
4. Real-life case
4.1  Variation in the frizzled class receptor 6 (FZD6) protein found in 
individuals with the nail disorder
Nonsyndromic congenital nail disorder 1 (OMIM #1161050) is a condition 
affecting the fingernails and toenails characterized by extremely thick nails, 
onycholysis, hyponychia and claw-like appearance. Autosomal recessive mutations 
in the FZD6 gene (OMIM *603409) were found to be associated with this disorder 
[110]. FZD6 is a member of the highly conserved WNT receptors family crucial for 
developmental processes and differentiation. The study conducted on mice demon-
strated that FZD6-mediated Wnt signaling has a regulatory role in the differentia-
tion process of claw/nail formation [111].
In a previous study from our group, a Turkish family with three affected indi-
viduals reported. After performing WES on the index case, 96 de novo heterozy-
gous, 421 homozygous, and 185 compound heterozygous variants were obtained 
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from data analysis. Employing population MAF frequency filtering according to the 
mode of inheritance has decreased the number of variants to 19, 46, 3 for de novo 
heterozygous, homozygous, compound heterozygous variants respectively. Further 
prioritization approaches were applied by integrating pathogenicity prediction 
scores provided by PrimateAI and other tools, model organism phenotypes, and 
gene intolerance scores. Ultimately, the FZD6 gene was found to be the most promi-
nent gene even though the gene does not have a high intolerance score. However, 
the potential functional impact of the mutation was supported by the examination 
of the evolutionary conservation of the disturbed amino acid region. The region 
was found to be evolutionarily conserved in other FZD6 orthologues including Pan 
troglodytes, Macaca mulatta, Pongo abelii, Bos taurus, Canis lupus familiaris, Rattus 
norvegicus, Mus musculus, Xenopus laevis. The index case had a homozygous 8 bp 
deletion on the FZD6 gene caused p.Gly559Aspfs*16. Additionally, this mutation has 
previously been reported in two other Turkish families. It is also reported that all 
three families have a common ancestor. In this study, the pathogenicity mechanism 
for this mutation in nail dysplasia is provided for the first time. The mutation causes 
a frameshift and creates a premature stop codon at position 16 of the new reading 
frame [112].
This case study demonstrated that the promising applications of evolutionary 
approaches assist the clinical diagnosis.
5. Conclusion
Associating genomic variants with diseases is a multistep process. The early 
steps of this process are highly automated through the usage of several bioinfor-
matics tools. However, the final prioritization step, which is the most critical step, 
is not completely automated. It requires a comprehensive interpretation together 
with integrative approaches. In this chapter, we aimed to explain the potential of 
integrating evolutionary principles into variant prioritization toward clinical utility. 
This chapter provides sufficient basic information to understand the required bio-
informatics tools, various databases with increasing sequence data from individuals 
as well as model organism research. Finally, we conclude that the pre-evaluation of 
individual variations with evolutionary approaches can help shorten the diagnostic 
odyssey, hence saving time and resources. This chapter aims to contribute to the 
integration of evolutionary genetics to medical genomics. Further studies that 
combine theoretical and analytical approaches are needed to improve the field of 
precision medicine via the use of evolutionary insight.
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